Skip to main content
Premium Trial:

Request an Annual Quote

Roche and ParAllele Partner on Diabetes SNP Discovery

NEW YORK, Sept. 16 (GenomeWeb News) - Roche and ParAllele BioScience have begun a research collaboration to discover genes and genetic variations related to type 2 diabetes, the companies said today.

Under the terms of the collaboration, which will focus on identifying new drugs and diagnostics to for the disease, Roche will provide clinical samples and funding to support the study, while ParAllele will use its SNP discovery and SNP genotyping platforms to discover genetic variations in the samples that are most often associated with type 2 diabetes.

Roche plans to further evaluate associations found during the study in a variety of larger patient populations. The companies did not provide further details about the collaboration.

ParAllele, which has signed SNP-based research collaborations with Baylor College of Medicine and Merck, said that the Roche project is the first commercial study that combines its SNP discovery platforms with high-throughput genotyping.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.